throbber
No. 3
`
`Chem. Pharm. Bull.]
`20.: 3 ) 443-451 (1972)
`
`(
`
`-·-·· -- ---- -·--- - -- - -- -
`
`443
`
`UDC 615. 31. 03. 076. 9
`
`Absorption of Drugs from the Skeletal Muscle of the Rats. (3). 11 Effect of Water(cid:173)
`soluble Adjuvants and Vehicles on the Intramuscular Absorption21
`
`K11cmRo KAKEMI (the late), Hnosm SEZAKI, KATSUHIKO OKUMURA,
`Hrnosm KOBAYASHI, and SHUNJI FuRUSAWA
`
`Faculty of Pharmaccutical Sciences, ]{yoto University 3>
`
`(Received June 15, Hl71)
`
`The effect of various kinds of acljuvants or vehicles was studied with a view to examine
`the mechanism of intramuscular drug absorption. From the relationship between in
`vivo absorption studies and various in vitro diffusion experiments, it was clarified which
`step was the rate-limiting one in the intramuscular absorption.
`1) The absorption mechanism of a drug with water-soluble adjuvants did not differ
`from that in aqueous solution without any adjuvant.
`2) There was a good correlationship between the parenteral absorption rate and the
`reciprocal of viscosity of an injectable solution, provided that the molecular weight of
`an acljuvant was comparatively small such as propylene glycol, glycerin, and PEG 400.
`Effect of these solvents on the drug absorption was general in nature and not specific to
`<lrugs.
`In the case of an adjuvant having higher molecular weight such as PEG 4000
`dextran, and 1nethylcellurose, rate of drug absorption was greater than that expected
`from the viscosity, suggesting that macromolecules could hardly diffuse through the pores
`of the capillary wall.
`3) vrom in vitro diffusion stu(ly using Visking membrane, glass filter, and slice of
`muscle, it ,ms concluded that the contribution of the diffusion process through the pores
`of capillary \\·all was dominant compared with the one through the muscle fiber space.
`
`In the field of aqueous injectable solution, various kinds of adjuvants or vehicles are
`\\·idely used. Reviev.:s4 •51 are reported on their toxicity or chemical and physical properties,
`and on their effect on the hemolysis of erythrocytes, 61 but few studies have been performed
`of their effect on the absorption mechanism.
`In the previous papers, 1 • 7l it was clarified that the intramuscular absorption of aqueous
`unionized drug solution from the injection site was chiefly proceeded by the apparent first
`order process and the diffusion through the pores of the capillary vessels was predominant
`compared with the penetration through the capillary endotherial cells. Therefore physico(cid:173)
`chemical properties of injectable solution may serve as a major role in the absorption process
`provided physiological condition was controlled normally.
`The purpose of this work was to examine the effect of the viscosity and the osmotic pressure
`on the ab$orption mechanism in the presence of adjuvants. From the relation between in vivo
`absorption study and in vitro diffusion rate analysis, it was clarified that the injected solution
`was absorbed from the injected site through muscle fiber space and then pores of capillary
`walls, and the latter step might act as the rate-limiting step in the absorptive process.
`
`1) Preceding paper, Part lI: Eiichiro Eakcmi, Hitoshi Sezaki, Katsuhiko Okumura, and Chiyoko Takada,
`Chem. Phanu . Bull. (Tokyo), 19, 2058 (Hl71).
`2) Part of this "·ork was presented at 89th Annual }\Jecting of the Pharmaceutical Society of Japan, Nagoya,
`April 1969.
`3) Location: Yoshidashinioadachi-cho, Sakyo-ku, J(yoto.
`. .\.J. Spiegel and M.M. Noseworthy, J. Pharm. Sci., 52, 917 (1963).
`4)
`5) E.S. Lin, J. Anschel, and C.J. Swartz, Bull. Parenteral Drug Assoc., 25, 40 (1971).
`6) D.E. Cad·wallader, ]. Pharm. Sci., 56, 351 (1967).
`i) IC I-:akemi, H. Sezaki, IC Okumura, and S. Ashida, Chem. Pharm. Bull. (Tokyo), 17, 1332 (1969).
`
`MYLAN INST. EXHIBIT 1086 PAGE 1
`
`MYLAN INST. EXHIBIT 1086 PAGE 1
`
`

`

`444
`
`Vol. 20 (1972)
`
`Experimental
`
`Materials--All drugs, isonicotinamidc and methylisonicotinate, and adjuvants, propylene glycol,
`glycerin, polyethylene glycol 400 (PEG 400), polyethylene glycol 4000 (PEG 4000), dextran (mol. wt. 70000)
`and methyl cellulose (4000 cps) were obtained from commercially available sources. All materials, but for
`PEG 4000 and methyl cellulose, were of analytical grade, and used without further purification. PEG 4000
`and methyl cellulose were of extra pure reagent.
`Procedure of Absorption Experiments--The absorption experiments were almost identical with those
`described in the previous paper from this laboratory. 1>
`Preparation of Solutions for Injection and Diffusion--Isotonic buffer systems and the concentration of
`drug solution were the same as previously described. 1>
`Determination of Possible Complexation of Dextran and PEG 4000 with Isonicotinamide--Ultraviolet
`spectrometry and equilibrium dialysis method were used.
`Determination of Viscosities--Viscosities were determined at 36° with B-type viscometer (Tokyo
`l{eiki Seisakusho).
`In the case of propylene glycol and dextran solution, it was confirmed that the solution
`was Newtonian fluid by the use of Universal Rheometer UR-1 of Shimazu Manufacturing Co., Ltd.
`Determination of Diffusion Coefficients--(A) A Glass Filter and Visking Cellulose Membrane as
`Diffusion Barrier: The apparatus used for this study is shown in Fig. 1. The apparatus consists of a jack(cid:173)
`eted glass beaker containing 100 ml of solvent without drug maintained at 37° by circulating water through
`the jacket. The beaker was closed on the top by a rubber stopper with one hole to keep the temperature
`constant and to prevent excessive evaporation. For the diffusion barrier, a glass filter (G-3) and a Visking
`cellulose membrane (Visking Co., Ltd., 24/32, 3 cm diameter) were used, the latter was firmly fixed by rubber
`band around the diffusion cell. All solutions were kept at 37° before use.
`In the diffusion cell,8> the test
`solution with 50 mM isonicotinamide was filled. The cell was then set to contact with the surface of the
`solution. Stirring of the solution was achieved by the use of a magnetic stirring bar throughout the whole
`experiment. Sample solutions of 0.5 ml were withdrawn every one hour in the case of a glass filter and
`every 30 minutes in the case of the Visking membrane through the hole, and after dilution with 5 ml of
`water, optical densities were measured at 270 m1t. The logarithmic plots of the residual amounts of iso(cid:173)
`nicotinamide in the diffusion cell versus time were straight line in c\·ery case, and the diffusion rate wa~
`obtained from the slope.
`
`C
`
`D
`
`-
`
`Fig. 1. Schematic Diagram of the
`Apparatus used to Study the Dif(cid:173)
`fusion Coefficient
`A: diffusion cell
`B :
`test solution
`C: diffusion barrier {galss filter or Visking
`cellulose membrane)
`D: solvent
`· E: magnetic stirring bar
`F : glass tu be for sampling
`
`Fig. 2. Schematic Diagram of the
`Apparatus used to study the Per(cid:173)
`meability Constant
`A,A': cell
`B: ground-glass end
`C: Visking cellulose mc1nbrane
`D: magnetic stirring bar
`
`8) Volumes of diffusion cells of Visking membrane and of glass filter were about 4.5 cm3 and 6.8 cm3
`respectively.
`
`~
`
`MYLAN INST. EXHIBIT 1086 PAGE 2
`
`MYLAN INST. EXHIBIT 1086 PAGE 2
`
`

`

`No. 3
`
`445
`
`(B) Slice of ~foscle as Diffusion Barrier: The experiments were almost identical with those described
`in the previous paper from this Jaboratory. 1>
`Determination of Apparent Membrane Permeability-
`- The whole apparatus•> for the permeability
`study, shown in Fig. 2, consisted of two glass cells, whose volume was about 7 to 8 cm3 • The same Visk(cid:173)
`ing membranes as used in fig . 1 were prepared and attached tightly between the ground-glass end of the
`glass cell by the rubber bands. The area of the membrane available to p ermeate was about 5 to 7 cm 2 •
`. .\11 solutions were kept at 37 ° before use.
`In the cell A, the test solution with 50 mM isonicotinamide was
`filled and, in the cell A', the same solution without drug was :filled. The entire cell was maintained at 37°
`by immersing in a constant-temperature water bath. Stirring of the solution was achieved by using magne(cid:173)
`tic stirring bars and stirring rate was adju sted so as not to affect the permeability . After 2 or 3 hour ex(cid:173)
`periment, the drug concentration of each cell " ·as measured, and apparent m embrane permeability was
`calculated. 10>
`Analytical Methotls---Thc spectrophotometric determination was applied to all the drugs investigated.
`Isonicotinamide: 1 n absorption experiments, same spectrophotometric methods were used as
`i)
`desc ribed previously. 1> 1:or the determination of the samples other than the absorption experiments, 5 ml
`of distilled water was adcled to 0.5 ml sample solution and its optical density was me<J.sured at 270 m1t.
`ii) Methylisonicotinatc :
`In absorption experiments, same spectrophotometric methods were used
`as previously described. 7>
`J n absorption experiments, removed muscle was homogenized and centri(cid:173)
`iii) Propylene Glycol:
`fu gated in the manner as d escribed prcYiously. 7> Supernatant, depr.oteinized by trichloroacetic acid, was
`u sed as 0.5 ml sample solution and 0.5 ml of distilled water, 0.5 ml of 0.lN hydrochloric acid, and 5 ml of
`1.6 % w/v sodium metabisulfite were added. After centrifugation, 1 ml of supernatant was separated.
`Then 2.5 ml of chromotropic acid solution, prepared by solubilizing 200 mg of chromotropic acid in 2 ml
`of distilled water and sufficient sulfuric acid to make 50 ml under cooling in ice-bath, was added, and the
`aliquot was boiled for 30 minutes. After cooling, 10 ml of sulfuric acid was added and the optical density
`,Ya s determined at :i65 m11.
`
`Result and Discussion
`
`Contrary to such pharrn.aceutical dosage form as suspensions, 11> oily solutions,12> and
`emulsions, 13> very little has been understood about the effect of vehicles on the absorption of
`aqueous injection solutions.
`(I) Effect of Adjuvants on the Time Course of Drug Clearance
`For the purpose of examining the possibility of change in the absorption mechanism
`caused by these adjuvants, the time course of drug clearance in the rat rn.uscle was investi(cid:173)
`gated. According to our previous paper,1> it was proved that the time course of the drug
`absorption from aqueous solution followed in most cases apparent first-order kinetics. Figure
`3 shows the logarithrn.ic plots of the amounts of isonicotinamide remaining in the muscle versus
`time after injection of 10 µl of 40% propylene glycol solution and 10% dextran solution. As
`is evident from the figure, straight lines were obtained in both cases, which shows that the
`absorption was proceeded by the apparent first-order kinetics. Accodingly, it was suggested
`that the absorption mechanism of the drugs with water-soluble adjuvants did not essentially
`differ from that in aqueous solution without any adjuvant.
`(2) Effect of Injection Volume in the Presence of Adjuvants
`As reported in the previous papers,1 •7> it was suggested that the parenteral absorption
`from aqueous solution was not affected by the variation of the injection volume. So the effect
`of injection volume was also examined in the presence of adjuvants. Absorption of isonico(cid:173)
`tinamide within 3 min when 40% propylene glycol or 10% dextran was added to injectable
`solution is shown in Fig. 4. No remarkable difference on absorption was observed between
`
`9) This apparatus was originally designed by Prof. ~Iasayuki Nakagaki of I-Cyoto University and Mr. l\fasa-
`katu Yonese of Nagoya City University.
`10) M. );'akagaki a nd i\l. I(oga, Yakugaku Zasshi, 82, 1134 (1962).
`11) F.H. Buckwalter and H.L. Dickson,]. Phann. Sci., 47, 661 (1958).
`12) J .C. Bauernfeind and H.L. Newmark, Bull. Parenteral Drug Assoc., 24, 169 (l!l70).
`13) J .J. \.Vindhcuser, i\I.L. Best, a nd J .H. Perrin, Bull. Parenteral Dnig Assoc., 24, 286 (l 9i0).
`
`MYLAN INST. EXHIBIT 1086 PAGE 3
`
`MYLAN INST. EXHIBIT 1086 PAGE 3
`
`

`

`446
`
`100
`
`"Cl
`~ 50
`·;;;
`s
`
`V
`h
`~ 20
`
`40% propylene glycol
`solution
`
`1
`
`3
`
`5
`Time (min)
`
`10% dextran solution
`
`1
`
`3
`
`5
`
`Fig. 3. Clearance Curves for Isonicotinamide
`Each point represents the mean value of at least five
`experiments. Vertical bars indicate S.D.
`
`Vol. 20 (1972)
`
`100
`
`-I-I-I-
`
`-11-I-
`
`40% propylene
`glycol
`
`solution
`
`10°~ dextran solution
`
`5
`
`10
`
`10
`5
`20
`Injection volume (µl)
`
`:rig. 4. Effect of Injection \"olumc on Parcnkral
`Absorption
`
`these two vehicles in the range of injection volume investigated. This suggests that there is
`little possibility of physiological alteration caused by adjuvant.
`As the further study for confirming whether the decrease of absorption accompany with
`the increase of the amount of propylene glycol, influence of pre-treatment by adjuvant on
`parenteral absorption was examined.
`In this experiment, 10 µl of 40% propylene glycol
`without drug was injected initially and 5 min after the first injection, when propylene glycol
`was expected to be mostly absorbed, the absorption of 50 mM isonicotinamide within 3 min
`was measured by injection of aqueous drug solution into the same injection site. No signi(cid:173)
`It is conceivable, therefore, that
`ficant difference caused by pre-treatment was observed.
`there is little possibility of change in the absorption mechanism caused by the local effect of
`the adjuvants.
`(3) Effect of Osmotic Pressure
`Hydrophilic pharmaceutical solvents are usually incorporated in very high concentrations
`and, in this experiment too, fairly high concentrated solutions were used. Therefore, the
`osmotic pressure of the injected solutions with the solvents of small molecular weight is
`naturally hypertonic. Thus the effect of osmotic pressure on the absorption was examined,
`particularly on the hypertonic range.
`In this
`Effect of osmotic pressure on the absorption from muscle is shovvn in Fig. 5.
`case N,N-dimethylacetamide, a non-aqueous solvent of which the contribution of viscosity
`is almost negligible, was added to 50 mM isonicotinamide solution to make the osmotic pressure
`of the final injection solution in the range of 50 moslVI to 3 osM which exceeds the physiological
`osmotic pressure. As is evident from the figure, no significant difference of the absorption
`was observed either in isotonic or in hypertonic range, which rule out the possible effect of
`osmotic pressure of the solvents on the drug absorption.
`(4) Effect of Adjuvant on Drug Absorption
`(A) Contribution of Viscosity--In Fig. G is shmvn the result of the examination of the
`effect of propylene glycol on absorption in which the left vertical axis is for the absorption
`rate constant, the right vertical one for the reciprocal viscosity. The horizontal one for the
`concentration of propylene glycol in pH 7.0 phosphate buffer. The solid line indicates the
`absorption rate constant calculated from the percentage-absorbed within 3 min and the
`dotted line denotes the reciprocal of viscosity. Good correlationship was obtained between
`these two parameters. Absorption rate of propylene glycol itself is indicated by the mark
`((cid:143)).
`As shown in this figure, absorption rate constant of isonicotinamide and that of pro(cid:173)
`pylene glycol are very close. The observed results rationalize the view that both of the
`components are absorbed by the same route.
`In other words this suggests that in the case
`of unionized drug such as isonicotinamide, drug is not separated from the solvent but is
`transported together ,vith the solvent into blood thus the viscosity of the solvent affects the
`
`MYLAN INST. EXHIBIT 1086 PAGE 4
`
`MYLAN INST. EXHIBIT 1086 PAGE 4
`
`

`

`No. 3
`- - - - · - - - - - - - - --
`
`100:-
`:
`
`I l :~-1-I--~
`~ 5o;t
`I
`I
`
`1 - - - I -
`
`300
`
`1500
`Osmotic pressure (mosl\1)
`
`3000
`
`Fig. il. Effect of Osmotic Pressure on Par(cid:173)
`enteral Absorption
`vehicle: N,N-<limethylacdamick - wakr
`drug:
`isonicotinamidc
`
`-
`0.6 -
`c
`"' "' 0.5:>;

`\
`~ 0.4 \ \ \
`J 0.1
`
`- 1.5
`
`0.5
`
`',a',,,,,:~.
`
`o.si
`
`7·r\
`1 o.
`
`•
`
`~ 0.3 -
`c 0.2 -
`
`'-
`a,
`',,,, •~
`
`----~------.\.
`o-~zc-'co- -40
`60
`80
`100
`Concentration of propylene glycol ( v/ v) %
`
`.
`
`Fig. 7. Effect of Propylene Glycol on
`the Absoption Rate Constant of Methyl
`Isonicotinate
`-------= absorption rate constann of mrthyl iso(cid:173)
`nicotinate
`- 0 -: reciprocal oi viscosity
`
`447
`
`1.0 ~
`'
`
`~
`
`0.5 .-.
`-------
`
`100
`80
`60
`40
`20
`0
`Concentration of propylene glycol (v/v) %
`
`Fig. 6. Effect of Propylene Glycol on
`the Absorption Rate Constant of Iso(cid:173)
`nicotinamide and Propylene Glycol
`
`-------: absorption rate constant of isonicotinamide
`D
`: absorption rate constant of propylene glycol
`---0---: reciprocal of viscosity
`
`1.0
`
`7
`
`~
`
`0.5 .-.
`-------
`
`100
`Concentration of glycerin (v/ v)%
`
`Fig. 8. Effect of Glycerin on the
`Absorption Rate Constant of Iso(cid:173)
`nicotinamide
`-------= absorption rate constant of iso(cid:173)
`nicotinamide
`---O---: reciprocal of viscosity
`
`absorption remarkably. This relationship was also reported by Coles, et al. in the absorption
`experiment of various vaccine formulation administered subcutaneously. 141
`Further examination was made about methylisonicotinate, a drug having high lipid
`solubility. Similar tendency with the case of isonicotinamide, shown in Fig. 7, suggests that
`the nature of the effect of these solvents on drug absorption is not of specific to drugs. The
`absorption rate of methylisonicotinate is larger than that of isonicotinamide by some de(cid:173)
`finite value, which is independent of propylene glycol concentration. This difference can be
`In general, the diffusion process
`attributed to the greater lipid-solubility of the former.
`through pores of the capillary wall and the partition process through the lipid component
`
`1-!) C.L.J. Coles, K.R. Heath, M.L. Hilton, K.A. Lees, P .W. Muggleton, and C.A. ·walton, ]. Pharm. Pharma(cid:173)
`col., 17 (Suppl .), 87s (l!l65).
`
`MYLAN INST. EXHIBIT 1086 PAGE 5
`
`MYLAN INST. EXHIBIT 1086 PAGE 5
`
`

`

`448
`
`Vol. 20 (1972)
`
`of the vascular endothelial cells have been reported for the mechanism of capillary permeability.
`In the latter process which is considered to be more dependent on lipid solubility, effect of
`the water-soluble adjuvants is comparatively small.
`In the limited sense, parenteral drug
`absorption with such adjuvant seem.s to be proceeded dominantly by the former process.
`Similar examination was made for other vehicles such as glycerin, and PEG 400. The results
`are shown in Fig. 8 and. Fig. 9, respectively. As is shown in the figures, good corre1ationship
`between parenteral absroption rate and the reciprocal of viscosity was obtained.
`On the basis of these experiments, it may be proposed that the prediction of the parenteral
`absorption rate of a drug from the injectable solution could be possible by the viscosity of the
`solvents, provided that the solvents are of comparatively small molecular weight and exert
`little local effect. On the other hand, in the case of adjuvants of macro molecules such as
`PEG 4000, dextran, and methyl cellulose, size of molecules outweighs the viscosity. As
`
`I
`- ,
`- 0.5?-
`
`c 0,4
`rs
`:§ 0.3
`
`<;;
`
`2
`e 0.2 •
`.:: c,
`e- 0.1
`.B
`<
`
`' ·
`,0.5 -
`I
`I
`····~>-- . .. .. ' .
`80 mo
`0
`40
`60
`20
`Concentration of PEG 4000
`
`Q
`
`Fig. 10. Effoct of P EG 4000 on the
`Absorption Rate Constant of lso(cid:173)
`nicotinamide
`-e-w-< Jhsorption rate con~tJnt of i:;o .
`nicotinamidc
`- (;,- : r1~ciprc~ l of vitcosi ty
`
`,,-.
`j
`7c: .0.5o
`
`:~
`
`..., .0.4
`t:::
`"'
`ti
`§ 0.3
`'-'
`e 0.2
`"'
`
`\
`
`',
`I
`I
`\ •
`
`I
`
`.. 1.0 -
`
`---~
`· 0.5 ,....
`
`100
`Concentration of PEG 400 (v/v)%
`
`F ig. 9. Effect of PEG 400 on the
`Absorption R ate Constant of Iso(cid:173)
`nicotinamidc
`¥-•··--: absorption rate constant of iso¥
`.njcotin.an1ide
`,. .... i:.)--:"""; r r.::ciprocal of vlsCO$i.ty
`
`.. 1.0
`
`.,.
`0.5 :::;
`
`20
`15
`5
`Concentration of dextran (w/v)%
`
`Fig. 11. Effect of Dextran on the
`Absorption Rate Constant of Iso(cid:173)
`nicotinamide
`--e-: absorption rate constant of iso(cid:173)
`n!co!inamide
`.... ,.C ...... : reciprocal of viscosity
`
`Fig. 12. Effect of Methyl Cellulose on
`the Absorption Rate Constant of Iso(cid:173)
`nicotinamicle
`-•-: absorption rate constant of is.onkotinaxnide
`--~()---: f.c-tlprocal of viscosity
`
`MYLAN INST. EXHIBIT 1086 PAGE 6
`
`MYLAN INST. EXHIBIT 1086 PAGE 6
`
`

`

`No. 3
`
`449
`
`shown in Fig. 10, ll, and 12, absorption rate is greater than that expected from the
`It is proper to consider that the vvater-soluble solution injected into muscle is
`viscosity.
`transported into blood from the injection site through tvvo steps ; as the first step, it diffuses
`through the intercellular space of muscle fiber or connective tissue, and as the second step, it
`diffuses through the pores of the capillary wall. According to Pappenheimer,15l the pore
`radius of capillary wall is 30-40 A, while the intercellular space is much larger than that.
`
`41.0 "' -:;;
`
`'"'?
`
`'1.0 2
`
`k
`c::
`c 0.4
`0
`·u;
`£!
`:£
`c:: 0.3 ..
`:.;
`0
`.....
`'-'
`· 0.5 0
`.3
`"' 0.2 ..
`~
`k
`\.;')
`"' k
`c::
`e 0.1
`•-,,..,
`0
`/':,. ,..._"
`"'
`•!;
`·c,
`---·---1 -a:;
`cu
`"'
`.:. <
`;:::::
`100
`60
`80
`40
`0
`20
`Concentration of propylene glyeol (v/v) %
`
`0.5~
`\
`\
`\
`
`\
`\
`
`:\
`
`!'.
`
`\
`
`:✓;
`
`0
`
`Fig. 13. Relationship between the Absorp(cid:173)
`tion Rate Constant and the Diff usion of
`Isonicotinamide with Propylene Glycol
`added as an A.djuvant
`--e-: absorption rate colliltant o! isonicolinamide
`O ; di(!nslon of isoo.icctinamidc thtough the
`Visking memhran0
`: diffusloo of lwoicotinumido through the
`glnss filter
`
`f::,
`
`Fig. 14. Relationship be tween the Absorp(cid:173)
`tion Rate Constant a11d the Diffusion of
`Isonicotinamide with Dextran added as
`an Atljuvant
`- -~ absorption rate constant of isonicotinmnid e
`- ··-: r ociprocal of viscosity
`O ; diffusion of isonicotinamicle through the Vi•
`sldng rne1nbr-.ane
`: diffusion of isonicotinamide through the glass
`Jilt~,
`
`6
`
`(B) Contribution of Diffusion Rate--ln order to gain further insightinto the nature of
`intramuscular absorption of drugs from aqueous vehicles, various diffusion experiments have
`been undertaken.
`In these experiments, cellulose Visking 1nembrane with similaT pore size
`with capillary pores (average pore size of about 24 A) and the glass filter (No. 3) (average pore
`size of about 40-20 µ) were used for diffusion b arrier. Fig. 13 is the result of diffusion of
`isonicotinamide with propylene glycol added as an adjuvant of low molecular weight. The
`left vertical axis is for absorption rate constant and the right vertical one for the value of
`the relative ratio of the diffusion rate without adjuvant to that with the adjuvant of respective
`concentration. As is evident from the figure, all these three plots have slwwngood correlation(cid:173)
`ship.
`As for dextran which belong to the adjuvants of macro molecular group, results of the
`In this adjuvant, good correlation was obtained with the
`experiments are shown in '.Fjg, 14.
`absorption curve when the Visking membrane was used. However in the case of glass filter
`the plots appeared almost on the curve of the reciprocal of viscosity. These results again
`indicate that, in the case of the solvent of small molecular weight such as propylene glycol,
`the solvent molecule itself permeates into the blood through pores of capillary wall, the drug
`and the solvent are transported together, so that the rate of transportation is rather limited
`by the solvent viscosity.
`\iv11en PEG 4000, dextran or methyl cellulose, which does not
`easily penneate the capillary wall by themselves, was added as an adjuvant, the transportation
`through the capillary wall is now becomes a rate-limiting step. The drug and the adjnvant
`
`15) J .TC Pappenheimcr, Physi<,l. Rw., 33, 387 (19flH).
`
`MYLAN INST. EXHIBIT 1086 PAGE 7
`
`MYLAN INST. EXHIBIT 1086 PAGE 7
`
`

`

`450
`
`Vol. 20 (1972)
`
`are presumably separated and only the former diffuses through pores of capillary wall as the
`simple aqueous solution. This may be considered to be the reason why the absorption rate
`It is conceivable also
`i'.n vivo is greater than the one anticipated from the solvent viscosity.
`that the pharmacological effect of dextran itself, £,e. enhancement of capillary permeability
`caused by histamine release,1m should be taken into consideration. Schou, however, demon(cid:173)
`strated that the self-depression of drug absorption was very pronounced when the injected
`drug is a chemical histamine liberator,m and in our experiments such effect is considered
`to be of little account.
`
`0.5\
`
`~ 0.4
`"' ti
`3 0.3
`
`CJ
`~ 0.2 -
`
`.
`
`(l
`b.\
`\
`\. , .. :,
`
`0
`20
`40
`60
`80
`Concentration of propylene glycol { v/v) %
`
`Fig. 15. Relationship between the
`Absorption Rate Constant ·and the
`Apparent Membrane P ermeability
`through
`the Visking Membrane,
`Permeability through the Slice of
`Muscle
`: absorption rate constant of isonicotinamjde
`/\ : pcnneahility of isonico!innmide tbroug'h
`the Visking membrane
`O : permeability of isonicotin;:nnide through
`the slice of mu.scle
`
`-
`
`CJ
`
`~ 0.2 ·
`
`C:
`0
`-~ 0.1
`0
`,:£
`<:
`
`C
`
`C
`
`20
`15
`10
`5
`0
`Concentrat.ion of dextran ( w /v) %
`
`Fig. 16. Relationship between the Absorp(cid:173)
`tion Rate Constant and the Apparent
`Membrane Permeability
`through
`the
`Visking Membrane, Permeability through
`the Slice of Musch:
`! ahsorptinn rate constant of- isonicoUoamid,~
`.. : r,~dprocal of vbcosi ty
`D. ; permeability of isonicotlnatnide through the
`Viski ng 1n<:mbranc
`O : permeahi1Hy of isonicoiinan1id11 through ill(>
`sliee t>{ musk<'
`
`...... H
`
`-
`
`(C) Contribution of Apparent .Membrane Permeahility---For the purpose of further
`confirm.ation, apparent membrane permeability of isonicotinami<le through the same cellulose
`Visking m.embrane as that used in the previous diffusion experiment was examined. Results
`of propylene glycol and dextran are shown in Fig. 15 and Fig. lG, respectively. The right
`vertical axis denoted the value of the relative ratio of the apparent membrane permeability
`without adjuvant to that when the adjuvant of respective concentration is added.
`In the
`case of propylene glycol, a good correlation was observed between the absorption rate -in vivo
`and the 1u.em.brane permeability. However, in the case of dextran, relative ratio of the
`apparent membrane penneability is greater than the ratio of diffusion rate. Particularly,
`in the range of low concentration of dextran, such as 5% w/v, the ratio of apparent membrane
`permeability is almost unity.
`It m.ay be concluded that vvith the solvent of small rnolecu1er weight such as propylene
`glycol, the pore of the cellulose membrane is filled ·with propylene glycol solution so that the
`membrane permeability of isonicotinamide is rather limited by the solvent viscosity. On
`the other hand, dextran cannot easily penneate the pores of the cellulose membrane and
`isonicotinaiuide molecules have to diffuse through the pores filled with water. At the rm1ge
`
`16) RH. l'oyser and G.B. West, Brit. ]. P/w.rmacol., 25, 602 (19G5).
`17) J. Schou, Nature, 182, 324 (Hl58).
`
`MYLAN INST. EXHIBIT 1086 PAGE 8
`
`MYLAN INST. EXHIBIT 1086 PAGE 8
`
`

`

`Nu. 3
`
`451
`
`(I)
`
`7>------
`
`B
`
`(II)
`
`of high concentration of dextran, howe,·er, the pore masking effect of dextran becomes pre(cid:173)
`dominant thus reduces the apparent membrane permeability.
`In the present report tvvo apparatus with
`Yisking membrane as the barrier have been used
`to investigate the mechanism of intramuscular
`absorption of drug with water-soluble adjuvant.
`The concentration gradients in each apparatus
`and in the case of practical intramuscular in(cid:173)
`jection are shown in Fig. 17. Considering the
`correlationship between in vivo absorption data
`and in vitro diffusion data, it may be concluded
`that, in our experim.ental condition, the diffusion
`apparatus shown in Fig. 1 is the most promi(cid:173)
`sing one for the investigation of the mecha(cid:173)
`It
`nism of intramuscular absorption of drug.
`is also suggested that in the case of macro(cid:173)
`molecules, the absorption process through the
`intracellular space or its masking effect could not
`be neglected in determining the rate of drug
`absorption.
`(D) Contribution of Permeability through Iso(cid:173)
`lated Muscular Slices--Finally to confirm
`the foregoing considerations, we have examined
`the permeability of the drug through isolated
`muscular slices. The result is shown in Fig. 15 and Fig. 16. As can be seen cleary from Fig.
`15 the ratio of diffusion rate to the control declines with the increase of the concentration of
`propylene glycol. Both isonicotinamide and prolylene glycol permeated the slice of muscle
`almost at the same rate, which agrees with the data obtained in the in vivo absorption ex(cid:173)
`periment. On the other hand, as shown in Fig. 16, diffusion rate decreases with the increase
`of the concentration of dextran, which can be explained by the increase of its viscosity. This
`data differs significantly from the absorption data in vivo. Consequently results of muscle
`slice diffusion experiment on dextran could be interpreted that the contribution of the dif(cid:173)
`fusion process through the pores of capillary wall to the drug absorption is do~inant compared
`,,·ith the process through the muslce fiber space. This again supports our conclusion.
`
`depo~;jf--_b_lo_od_
`
`Fig. 17 . Model of Drug Concentration
`Gradient
`A: apparatus shown in Fig. 1
`B : apparatus shown in Fig. 2
`C : practical intramuscular injection
`(I) Visking membrane
`(II) capillary wall
`
`MYLAN INST. EXHIBIT 1086 PAGE 9
`
`MYLAN INST. EXHIBIT 1086 PAGE 9
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket